Results Snapshot
Figures in Million
Consolidate Annual Results
Aug'24
Aug'23
Aug'22
Aug'21
Aug'20
Aug'19
Aug'18
Net Sales
81.75
57.26
35.84
17.02
2.55
2.10
0.43
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
81.75
57.26
35.84
17.02
2.55
2.10
0.43
Raw Material Cost
78.89
52.09
30.91
13.77
6.35
6.12
0.38
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
3.82
5.15
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
5.66
5.30
3.31
1.73
1.36
1.53
0.32
Selling and Distribution Expenses
19.65
13.52
10.03
7.30
5.15
6.20
1.87
Other Expenses
-0.45
-0.43
-0.21
0.02
-0.26
-0.67
-0.03
Total Expenditure (Excl Depreciation)
99.66
66.64
42.20
22.98
14.09
12.32
2.25
Operating Profit (PBDIT) excl Other Income
-17.9
-9.399999999999999
-6.4
-6
-11.5
-10.2
-1.7999999999999998
Other Income
2.49
0.47
0.24
0.14
0.26
0.66
0.03
Operating Profit (PBDIT)
-9.06
-3.97
-2.19
-2.79
-8.70
-9.00
-1.68
Interest
5.66
5.30
3.31
1.73
1.36
1.53
0.32
Exceptional Items
25.56
21.15
11.73
6.02
-0.45
-1.88
0.00
Gross Profit (PBDT)
2.86
5.17
4.93
3.25
-3.79
-4.03
0.05
Depreciation
6.35
4.94
3.92
3.03
2.58
0.57
0.11
Profit Before Tax
4.48
6.95
2.31
-1.53
-13.09
-12.97
-2.11
Tax
-1.95
0.00
0.00
0.00
0.00
0.00
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
6.44
6.95
2.31
-1.53
-12.48
-12.32
-2.11
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
6.44
6.95
2.31
-1.53
-12.48
-12.32
-2.11
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
-0.61
-0.66
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
6.44
6.95
2.31
-1.53
-13.09
-12.97
-2.11
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
87.95
79.74
66.74
64.12
38.36
47.16
14.74
Earnings per share (EPS)
0.07
0.08
0.03
-0.02
-0.17
-0.17
-0.03
Diluted Earnings per share
0.07
0.08
0.03
-0.02
-0.17
-0.17
-0.03
Operating Profit Margin (Excl OI)
-21.91%
-16.39%
-17.73%
-35.03%
-452.56%
-487.52%
-420.01%
Gross Profit Margin
13.26%
20.76%
17.37%
8.8%
-412.08%
-591.59%
-463.03%
PAT Margin
7.88%
12.13%
6.43%
-8.98%
-489.35%
-587.28%
-488.38%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Aug 2024 is 42.58% vs 60.06% in Aug 2023
Consolidate Net Profit
YoY Growth in year ended Aug 2024 is -7.25% vs 200.00% in Aug 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Aug 2024 is -163.64% vs -83.33% in Aug 2023
Interest
YoY Growth in year ended Aug 2024 is 7.55% vs 60.61% in Aug 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Aug 2024 has fallen from Aug 2023
Compare Annual Results Of Cannara Biotech, Inc. With
Figures in Million
Consolidate Annual Results
Change(CAD)
Change(%)
Net Sales
81.75
34.51
47.24
136.89%
Other Operating Income
0.00
0.00
0.00
Total Operating income
81.75
34.51
47.24
136.89%
Raw Material Cost
78.89
16.41
62.48
380.74%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
12.42
-12.42
-100.00%
Power Cost
0
0
0.00
Manufacturing Expenses
5.66
2.64
3.02
114.39%
Selling and Distribution Expenses
19.65
21.56
-1.91
-8.86%
Other Expenses
-0.45
-0.89
0.44
49.44%
Total Expenditure (Excl Depreciation)
99.66
44.08
55.58
126.09%
Operating Profit (PBDIT) excl Other Income
-17.91
-9.57
-8.34
-87.15%
Other Income
2.49
-0.66
3.15
477.27%
Operating Profit (PBDIT)
-9.06
-8.52
-0.54
-6.34%
Interest
5.66
2.64
3.02
114.39%
Exceptional Items
25.56
-4.80
30.36
632.50%
Gross Profit (PBDT)
2.86
18.10
-15.24
-84.20%
Depreciation
6.35
1.71
4.64
271.35%
Profit Before Tax
4.48
-17.68
22.16
125.34%
Tax
-1.95
0.01
-1.96
-19,600.00%
Provisions and contingencies
0
0
0.00
Profit After Tax
6.44
-17.69
24.13
136.40%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
6.44
-17.69
24.13
136.40%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
6.44
-17.69
24.13
136.40%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
87.95
1.91
86.04
4,504.71%
Earnings per share (EPS)
0.07
-1.09
1.16
106.42%
Diluted Earnings per share
0.07
-1.09
1.16
106.42%
Operating Profit Margin (Excl OI)
-21.91%
-27.75%
0.00
5.84%
Gross Profit Margin
13.26%
-46.27%
0.00
59.53%
PAT Margin
7.88%
-51.27%
0.00
59.15%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 8.17 Million
in Aug 2024Figures in Million
YoY Growth in year ended Aug 2024 is 42.58% vs 60.06% in Aug 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 0.64 Million
in Aug 2024Figures in Million
YoY Growth in year ended Aug 2024 is -7.25% vs 200.00% in Aug 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) -1.16 Million
in Aug 2024Figures in Million
YoY Growth in year ended Aug 2024 is -163.64% vs -83.33% in Aug 2023
Annual - Interest
Interest 0.57 Million
in Aug 2024Figures in Million
YoY Growth in year ended Aug 2024 is 7.55% vs 60.61% in Aug 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -21.91%
in Aug 2024Figures in %
YoY Growth in year ended Aug 2024 has fallen from Aug 2023






